Author

K. Lambert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:flow cytometry· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1

Frequent Co-Authors

A. Arnett· 1 shared A. E. Wiedeman· 1 shared A. Kolz· 1 shared A. Peters· 1 shared A.-C. Tan· 1 shared B. Khor· 1 shared B. Truong· 1 shared C. Ceol· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Arnett

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Memory Th1 cells modulate heterologous diseases through innate function

N. Rakebrandt, N. Yassini, A. Kolz, M. Schorer, K. Lambert, C. Rauld, Z. Balazs, M. Krauthammer, J. Carballido, A. Peters, N. Joller

This study identifies memory Th1 cells that can respond rapidly to unrelated pathogens or diseases through TCR-independent IFN-γ production, influencing susceptibility to heterologous challenges.

bioRxiv · Mar 22, 2023 · PreprintImmunology

Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity

K. Lambert, K. G. Moo, A. Arnett, G. Goel, K. J. Flynn, C. Speake, A. E. Wiedeman, C. J. Greenbaum, S. A. Long, R. Partridge, J. H. Buckner, B. Khor

The paper uses permutational analysis to reveal advanced immune aging in Down syndrome and type 1 diabetes.

bioRxiv · Sep 13, 2021 · PreprintImmunology

Loss of prdm1a accelerates melanoma onset and progression

R. Iwanaga, B. Truong, K. Lambert, R. Vyas, D. Orlicky, Y. Shellman, A.-C. Tan, C. Ceol, K. Artinger

This study shows that loss of PRDM1 accelerates melanoma onset and progression in zebrafish, with reduced PRDM1 expression linked to poor patient survival in humans.

bioRxiv · Dec 20, 2019Cancer Biology